We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 75 results
  1. Differentiating rhythmic high-amplitude delta with superimposed (poly) spikes from extreme delta brushes: limitations of standardized nomenclature and implications for patient management

    Background

    Following the standardized nomenclature proposed by the American Clinical Neurophysiology Society (ACNS), rhythmic high-amplitude delta...

    Rene Andrade-Machado, Elham Abushanab, ... Avantika Singh in World Journal of Pediatrics
    Article 12 July 2024
  2. Insights into Lewy body disease from rare neurometabolic disorders

    Professor Kurt Jellinger is well known for his seminal work on the neuropathology of age-associated neurodegenerative disorders, particularly Lewy...

    Daniel Erskine, Johannes Attems in Journal of Neural Transmission
    Article Open access 30 May 2021
  3. Rod bipolar cell dysfunction in POLG retinopathy

    Objective

    To report the clinical and novel electrophysiological features in a child with POLG -related sensory ataxic neuropathy, dysarthria and...

    Kit Green Sanderson, Eoghan Millar, ... Ajoy Vincent in Documenta Ophthalmologica
    Article 21 June 2020
  4. Antiepileptics

    Article 27 August 2022
  5. Neuromitochondrial Disorders

    Mitochondrial disorders have been an enigma for a long time due to the varied clinical presentations. Although a genetic confirmation will be...

    Santhakumar Senthilvelan, Sabarish S. Sekar, ... Bejoy Thomas in Clinical Neuroradiology
    Article 09 June 2021
  6. The evolution of the mitochondrial disease diagnostic odyssey

    Background

    Mitochondrial diseases often require multiple years and clinicians to diagnose. We lack knowledge of the stages of this diagnostic odyssey,...

    John L. P. Thompson, Amel Karaa, ... Michio Hirano in Orphanet Journal of Rare Diseases
    Article Open access 22 June 2023
  7. Heterozygous POLG variant Ser1181Asn co-segregating in a family with autosomal dominant axonal neuropathy, proximal muscle fatigability, ptosis, and ragged red fibers

    By whole-exome sequencing, we found the heterozygous POLG variant c.3542G>A; p.Ser1181Asn in a family of four affected individuals, presenting with a...

    Maike F. Dohrn, Corina Heller, ... Lejla Mulahasanovic in Neurological Research and Practice
    Article Open access 01 February 2022
  8. Neurogenetic disorders across the lifespan: from aberrant development to degeneration

    Intellectual disability and autism spectrum disorder (ASD) are common, and genetic testing is increasingly performed in individuals with these...

    Richard A. Hickman, Sarah A. O’Shea, ... Wendy K. Chung in Nature Reviews Neurology
    Article 05 January 2022
  9. Genetics of Mitochondrial Cardiomyopathy

    Purpose of Review

    Primary mitochondrial disorders (PMD) are a heterogeneous group of individual genetic multi-systemic diseases that are challenging...

    Atif Towheed, Amy C. Goldstein in Current Cardiovascular Risk Reports
    Article 10 February 2023
  10. Molecular basis of Leigh syndrome: a current look

    Leigh Syndrome (OMIM 256000) is a heterogeneous neurologic disorder due to damage in mitochondrial energy production that usually starts in early...

    Manuela Schubert Baldo, Laura Vilarinho in Orphanet Journal of Rare Diseases
    Article Open access 29 January 2020
  11. The burden of mitochondrial disease with associated seizures: systematic literature reviews of health-related quality of life, utilities, costs and healthcare resource use data

    Background

    Mitochondrial disease is a degenerative, progressive, heterogeneous group of genetic disorders affecting children and adults. Mitochondrial...

    Enrico Bertini, Emily Gregg, ... Ioannis Tomazos in Orphanet Journal of Rare Diseases
    Article Open access 11 October 2023
  12. POLG-related disorders and their neurological manifestations

    The POLG gene encodes the mitochondrial DNA polymerase that is responsible for replication of the mitochondrial genome. Mutations in POLG can cause...

    Shamima Rahman, William C. Copeland in Nature Reviews Neurology
    Article 19 November 2018
  13. Novel biallelic mutations in POLG gene: large deletion and missense variant associated with PEO

    Background

    Mitochondrial disorders are clinically heterogeneous diseases associated with impaired oxidative phosphorylation (OXPHOS) activity. POLG ,...

    Yan Lin, Jixiang Du, ... Chuanzhu Yan in Neurological Sciences
    Article 29 June 2021
  14. Movement disorders and neuropathies: overlaps and mimics in clinical practice

    Movement disorders as well as peripheral neuropathies are extremely frequent in the general population; therefore, it is not uncommon to encounter...

    Francesco Gentile, Alessandro Bertini, ... Tommaso Bocci in Journal of Neurology
    Article 03 June 2022
  15. Lipids, lysosomes and mitochondria: insights into Lewy body formation from rare monogenic disorders

    Accumulation of the protein α-synuclein into insoluble intracellular deposits termed Lewy bodies (LBs) is the characteristic neuropathological...

    Daniel Erskine, David Koss, ... Ian McKeith in Acta Neuropathologica
    Article Open access 30 January 2021
  16. Drug Treatment of Progressive Myoclonic Epilepsy

    The progressive myoclonic epilepsies (PMEs) represent a rare but devastating group of syndromes characterized by epileptic myoclonus, typically...

    Gregory L. Holmes in Pediatric Drugs
    Article 14 January 2020
  17. Ketogenic treatment reduces the percentage of a LHON heteroplasmic mutation and increases mtDNA amount of a LHON homoplasmic mutation

    Background

    The vision loss in Leber hereditary optic neuropathy patients is due to mitochondrial DNA mutations. No treatment has shown a clear-cut...

    Sonia Emperador, Ester López-Gallardo, ... Eduardo Ruiz-Pesini in Orphanet Journal of Rare Diseases
    Article Open access 21 June 2019
  18. Spectrum of movement disorders and neurotransmitter abnormalities in paediatric POLG disease

    Objectives

    To describe the spectrum of movement disorders and cerebrospinal fluid (CSF) neurotransmitter profiles in paediatric patients with POLG ...

    A. Papandreou, S. Rahman, ... Manju A. Kurian in Journal of Inherited Metabolic Disease
    Article Open access 30 August 2018
  19. Valproic-acid

    Article 28 April 2018
Did you find what you were looking for? Share feedback.